Galderma Investigational Site

Raleigh, North Carolina 27617

0 studies enrolling now · 3 studies all time

What they study most

Acne Vulgaris, Prurigo Nodularis

Studies at this site

• A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Running, not enrolling
• Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Completed
• Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris — Completed